Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingmen Shangqing Pill in recurrent oral ulcer (upper-jiao excess-heat pattern)
CTR20192027Phase 3Completed
- Sponsor
- Hubei Qijin Pharmaceutical
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Jingmen Shangqing Pill in aphthosis (RAS), sponsored by Hubei Qijin Pharmaceutical. Started Nov 2019; status: completed.
02
Drugs
Jingmen Shangqing Pill
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20192027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192027.